SynBioBeta Speaker
John Nicols
CEO
Organicols
As President & CEO since June 2012, John has lead the turnaround and growth of Codexis, the Nasdaq-listed protein engineering company (Ticker: CDXS). Prior to Codexis, John worked in various leadership roles for more than 22 years at Albemarle Corporation, a maker of highly engineered specialty chemicals. MBA from MIT Sloan; BS Chemical Engineering from NYU/Poly; Native of New York city.
SynBioBeta 2025 - Session Speaker
Infrastructure Investments for Accelerating the Bioeconomy
In this session, we'll discuss the pivotal role of infrastructure investments in accelerating the bioeconomy. Harnessing the full potential of synthetic biology requires access to expensive infrastructure for biomanufacturing and scale-up. We'll dive into how investors, CMOs, and startups are capitalizing on this opportunity space to accelerate bringing products to market.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Meals & Refreshments
Post Event Video Access
Price increases in
22:13:16:11
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
2026
Event Updates